Insight

Brandon Huffman: Exciting translational work happening at Dana-Farber Cancer Institute

Photo from Brandon Huffman/X

Feb 19, 2024, 09:20

Brandon Huffman: Exciting translational work happening at Dana-Farber Cancer Institute

Brandon Huffman, Medical Oncologist in the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, shared an X post by James Cleary, Medical Oncologist in the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, adding:

“Congratulations to Harsh Singh, James Cleary, and the team on a very well-done description of the unique entity – HER2 (ERBB2) amplified CRC! Exciting translational work happening at Dana-Farber Cancer Institute!”

Quoting James Cleary’s post:

“In this collaboration with Harsh Singh, Lab Sethi, Jason Hornick we examined mechanisms of resistance and sensitivity to targeted therapy in HER2 amplified colorectal cancer.”

Proceed to the article.
Source: Brandon Huffman/X and James Cleary/X

Brandon Huffman cancer colorectal cancer Dana-Farber Cancer Institute Dana-Farber Gastrointestinal Cancer Center Dana-Farber's Young-Onset Colorectal Cancer Center Harsh Singh HER2 amplified colorectal cancer James Cleary Jason Hornick Lab Sethi OncoDaily Oncology

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage